Nanomedicines Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Nanomedicine is the application
of nanotechnology to the advancement of healthcare. It makes use of a
material's 10-9 m nanometric scale properties, which frequently differ from
those of the same material at a larger size in terms of physics, chemistry, and
biology. Additionally, because many biological processes in the human body
operate at the nanometric scale, nanomaterials and nanoparticles may be able to
pass through natural barriers to find new delivery sites and interact with DNA
or small proteins there at different levels, whether in the blood or inside
organs, cells, or tissues.
Nanomedicine has the potential to
advance a variety of medical procedures, including cancer treatment, early
detection, and follow-up care. Clinical trials for hundreds of nanomedicine
items are now being conducted, covering all major diseases including
inflammatory, musculoskeletal, cardiovascular, and neurological conditions.
With over 80 marketed products ranging from medical imaging, biomaterials, and
diagnostics to nano-delivery and medications, nanomedicine is an enabling
technology in all areas of healthcare.
Over the forecast period, a high
frequency of chronic diseases is anticipated to fuel Nanomedicines market expansion. For
instance, the American Cancer Society predicts that there will be 606,880
cancer deaths and 1,762,450 new cancer cases in the United States in 2019.
Comments
Post a Comment